Article Text

Download PDFPDF

116 Analysis of histopathological features, molecular results and serum tumour markers in cases of fallopian tube involvement by metastatic gastrointestinal adenocarcinoma
Free
  1. M Basha Mohamed,
  2. A Haider and
  3. R Arora
  1. University College London Hospitals NHS Foundation Trust, UK

Abstract

Introduction Ovarian metastasis from non-gynaecological primary has been the focus of many studies with little attention given to tubal involvement. We present an analysis of tubal involvement by gastro-intestinal tract primary, the most common non-gynaecological metastasis to the adnexa.

Methods We evaluated cases of gastro-intestinal tract metastasis involving the fallopian tube over 5 years for histological patterns of involvement, molecular data and serum tumour markers.

Results Of the 12 cases which met the inclusion criteria, 2/12 cases (16.7%) had no prior history of gastro-intestinal adenocarcinoma. The metastatic adenocarcinoma involved the right tube in 3/12 cases (25%), left tube in 3/12 cases (25%), and bilateral tubes in 6/12 cases (50%).

Ovary was also involved in all but one case.

Tubal fimbrial end was involved in 3/12 cases (25%).

The metastasis had a flat mucosal pattern in 4/12 cases (33.3%); resembling mucinous metaplasia and serous tubal intraepithelial carcinoma (STIC). Other patterns seen were: extracellular mucin pools in 6/12 cases (50%), individual glands/cells in 6/12 cases (50%) and tumour sheets in 5/12 cases (41.7%).

Mismatch repair proteins were retained in all 9 cases in which they were tested.

Next generation sequencing detected mutations in 6/12 cases (50%), with KRAS being the most common mutation.

Serum CA125 was raised in 6/10 cases (60%), CEA in 9/12 cases (75%) and CA19.9 in 3/10 cases (30%).

Conclusion Awareness of various patterns of tubal involvement by metastatic gastro-intestinal adenocarcinoma is important to avoid misdiagnosis especially as the serum tumour markers can be variable.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.